Published in J Clin Microbiol on November 01, 1998
H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut (2004) 4.66
Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev (2007) 3.43
Molecular detection of antimicrobial resistance. Clin Microbiol Rev (2001) 2.31
Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol (2011) 1.98
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. J Clin Microbiol (1999) 1.62
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol (2003) 1.60
Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol (2001) 1.37
Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother (1999) 1.30
PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother (2002) 1.19
Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol (2003) 1.16
Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization. J Clin Microbiol (2001) 1.13
Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children. J Clin Microbiol (2007) 1.10
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol (2000) 1.09
Molecular testing for antibiotic resistance in Helicobacter pylori. Gut (2002) 0.92
Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. Ann Clin Microbiol Antimicrob (2003) 0.91
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob (2010) 0.90
Comparison of PCR-restriction fragment length polymorphism analysis and PCR-direct sequencing methods for differentiating Helicobacter pylori ureB gene variants. J Clin Microbiol (2000) 0.89
Clarithromycin resistance to Mycobacterium abscessus. J Clin Microbiol (2001) 0.89
Clarithromycin resistance in Helicobacter pylori and its clinical relevance. World J Gastroenterol (1999) 0.88
Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol (2013) 0.86
Detection of Helicobacter pylori in paraffin-embedded and in shock-frozen gastric biopsy samples by fluorescent in situ hybridization. J Clin Microbiol (2003) 0.85
Magnetic immuno-PCR assay with inhibitor removal for direct detection of Helicobacter pylori in human feces. J Clin Microbiol (2001) 0.84
Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR. J Clin Microbiol (2002) 0.84
Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori. Antimicrob Agents Chemother (2005) 0.83
Differentiation of metronidazole-sensitive and -resistant clinical isolates of Helicobacter pylori by immunoblotting with antisera to the RdxA protein. J Clin Microbiol (2001) 0.82
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. World J Gastroenterol (2016) 0.75
Genotyping of the Helicobacter pylori cagA Gene Isolated From Gastric Biopsies in Shiraz, Southern Iran: A PCR-RFLP and Sequence Analysis Approach. Jundishapur J Microbiol (2016) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics (1989) 19.10
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother (1997) 3.80
Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother (1997) 3.27
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter (1996) 3.13
Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol (1995) 2.75
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother (1997) 2.73
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63
Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett (1996) 2.42
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter (1996) 2.10
PCR amplification of specific alleles: rapid detection of known mutations and polymorphisms. Mutat Res (1993) 1.44
Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum Mutat (1994) 1.38
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut (1998) 1.32
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. Aliment Pharmacol Ther (1997) 1.25
Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1997) 1.22
Evaluation of performances of three DNA enzyme immunoassays for detection of Helicobacter pylori PCR products from biopsy specimens. J Clin Microbiol (1997) 1.10
Colorimetric microwell plate hybridization assay for detection of amplified Mycobacterium tuberculosis DNA from sputum samples. J Clin Microbiol (1995) 1.07
Rapid detection of Salmonella subspecies I by PCR combined with non-radioactive hybridisation using covalently immobilised oligonucleotide on a microplate. FEMS Immunol Med Microbiol (1995) 1.04
Detection of Bordetella pertussis by rapid-cycle PCR and colorimetric microwell hybridization. J Clin Microbiol (1996) 0.99
Rapid colorimetric hybridization assay for detecting amplified Helicobacter pylori DNA in gastric biopsy specimens. J Clin Microbiol (1996) 0.91
Sensitive identification of bluetongue virus serogroup by a colorimetric dual oligonucleotide sorbent assay of amplified viral nucleic acid. J Clin Microbiol (1993) 0.89
Simultaneous detection of delta F508, G542X, N1303K, G551D, and 1717-1G-->A cystic fibrosis alleles by a multiplex DNA enzyme immunoassay. Int J Clin Lab Res (1995) 0.84
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol (1997) 3.57
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother (1997) 3.27
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology (1999) 2.64
Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother (1986) 2.26
European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis (2001) 2.10
In vitro model for Campylobacter pylori adherence properties. Infect Immun (1988) 1.97
Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol Mol Biol Rev (1999) 1.92
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther (2003) 1.76
Matrix-assisted laser-desorption/ionization biotyper: experience in the routine of a University hospital. Clin Microbiol Infect (2011) 1.74
Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2000) 1.67
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother (2001) 1.60
GC content of DNA of Campylobacter pylori and other species belonging or related to the genus Campylobacter. Ann Inst Pasteur Microbiol (1989) 1.54
Laboratory-acquired Helicobacter pylori infection. Lancet (1995) 1.49
Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol (2001) 1.47
Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer (2000) 1.44
Development of a real-time fluorescence resonance energy transfer PCR to identify the main pathogenic Campylobacter spp. Clin Microbiol Infect (2005) 1.43
Haemophilus species in the human gastrointestinal tract. Eur J Clin Microbiol Infect Dis (1988) 1.42
Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol (1995) 1.42
[CagA status and virulence of Helicobacter pylori strains. Results of a French multicentric prospective study]. Gastroenterol Clin Biol (2001) 1.42
Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut (2005) 1.34
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut (1998) 1.32
Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother (1999) 1.30
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer (2003) 1.30
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics (1998) 1.25
Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother (1985) 1.25
Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors. J Microbiol Methods (2001) 1.25
In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother (2001) 1.24
Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole. Antimicrob Agents Chemother (1998) 1.23
Isolation of Campylobacter species by filtration. Eur J Clin Microbiol (1985) 1.22
Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut (2006) 1.20
Identification of Campylobacter species and related organisms by matrix assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. Clin Microbiol Infect (2011) 1.19
Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2001) 1.17
Epidemiology of Helicobacter pylori infection with special reference to professional risk. J Physiol Pharmacol (1997) 1.17
[Phenotype characteristics of 100 strains of Pseudomonas cepacia. Proposition of a biovars classification (author's transl)]. Ann Biol Clin (Paris) (1981) 1.15
A large multi-pathogen waterborne community outbreak linked to faecal contamination of a groundwater system, France, 2000. Clin Microbiol Infect (2006) 1.15
Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Aliment Pharmacol Ther (2009) 1.15
Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study. Aliment Pharmacol Ther (2003) 1.11
Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy. Am J Gastroenterol (1997) 1.10
Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. J Bacteriol (2010) 1.10
Evaluation of performances of three DNA enzyme immunoassays for detection of Helicobacter pylori PCR products from biopsy specimens. J Clin Microbiol (1997) 1.10
Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (2002) 1.10
Intragastric balloon for obesity. Cochrane Database Syst Rev (2007) 1.09
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection. Aliment Pharmacol Ther (1999) 1.08
Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb Drug Resist (2002) 1.08
A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut (1995) 1.07
Helicobacter pylori virulence genotypes in Portuguese children and adults with gastroduodenal pathology. Eur J Clin Microbiol Infect Dis (2003) 1.04
Isolation of a urease positive thermophilic variant of Campylobacter lari from a patient with urinary tract infection. Eur J Clin Microbiol Infect Dis (1990) 1.01
[Stomatococcus mucilaginosus: cultural and biochemical properties of 100 strains isolated from the ORL area]. Ann Inst Pasteur Microbiol (1985) 1.00
cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol (2001) 0.98
A redox basis for metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother (2009) 0.98
Evaluation of moxalactam with the BD phoenix system for detection of methicillin resistance in coagulase-negative staphylococci. J Clin Microbiol (2007) 0.97
Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type. Gut (2004) 0.97
The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection. Helicobacter (2000) 0.97
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies. Aliment Pharmacol Ther (2003) 0.96
[Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study]. J Fr Ophtalmol (2002) 0.96
Telematics: a new tool for epidemiological surveillance of diarrhoeal diseases in the Aquitaine sentinel network. BMJ (1990) 0.95
Rapid detection of Campylobacter jejuni and Campylobacter coli isolated from clinical specimens using the polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1995) 0.95
Investigation of an outbreak of Ralstonia pickettii in a paediatric hospital by RAPD. J Hosp Infect (2000) 0.94
Mucin exocytosis: a major target for Helicobacter pylori. J Clin Pathol (1993) 0.93
[Central pontine myelinolysis within the framework of a new histopathological syndrome with systematized topography. Report of an anatomo-clinical case]. J Neurol Sci (1971) 0.93
European multicentre validation trial of two new non-invasive tests for the detection of Helicobacter pylori antibodies: urine-based ELISA and rapid urine test. Aliment Pharmacol Ther (2003) 0.91
Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide. Dig Dis Sci (2001) 0.91
Staff burnout in a hospice setting. Hosp J (1985) 0.90
[Neurocysticercosis, a frequent parasitic disease in Portugal. 138 cases diagnosed by brain scanning]. Presse Med (1987) 0.90
Helicobacter species colonizing pig stomach: molecular characterization and determination of prevalence. Appl Environ Microbiol (1999) 0.90
Development of a real-time PCR for the identification of Bordetella pertussis and Bordetella parapertussis. Clin Microbiol Infect (2007) 0.90
Characterization of a Campylobacter fetus-like strain isolated from the faeces of a sick leopard tortoise (Stigmochelys pardalis) using matrix-assisted laser desorption/ionization time of flight as an alternative to bacterial 16S rDNA phylogeny. Lett Appl Microbiol (2013) 0.88
Quantitative polymerase chain reaction for the detection of Helicobacter pylori in gastric biopsy specimens. Eur J Clin Microbiol Infect Dis (1997) 0.87
Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model. Infect Immun (1998) 0.86
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther (2001) 0.85
Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut (2008) 0.85
Surveillance of human Campylobacter infections in France--part 2--implementation of national surveillance. Euro Surveill (2003) 0.85
Comparison of genetic profiles of Campylobacter strains isolated from poultry, pig and Campylobacter human infections in Brittany, France. Pathol Biol (Paris) (2008) 0.84
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. Am J Gastroenterol (1998) 0.84
What is the role of serology in assessing Helicobacter pylori eradication? Aliment Pharmacol Ther (2003) 0.84
Incidence and virulence of Aeromonas species in feces of children with diarrhea. Eur J Clin Microbiol (1986) 0.84
Antral gastric permeability to antigens in mice is altered by infection with Helicobacter felis. Eur J Gastroenterol Hepatol (1999) 0.83
Effect of bariatric surgery on weight loss, inflammation, iron metabolism, and lipid profile. Scand J Surg (2013) 0.83
Different modes of inhibition of mouse Cyp2a5 and rat CYP2A3 by the food-derived 8-methoxypsoralen. Food Chem Toxicol (2007) 0.83
Exercise-induced signs of muscle overuse in children. Int J Sports Med (1999) 0.83
Can Campylobacter coli induce Guillain-Barré syndrome? Eur J Clin Microbiol Infect Dis (2008) 0.83
Evaluation of the performance of the Helico Blot 2.1 as a tool to investigate the virulence properties of Helicobacter pylori. Clin Microbiol Infect (2002) 0.82
Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis. Scand J Gastroenterol (2000) 0.82
Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis. Mult Scler (2009) 0.82
New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report. Ital J Gastroenterol Hepatol (1998) 0.82
[Titration of anti-Campylobacter pylori by ELISA]. Gastroenterol Clin Biol (1988) 0.82
Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients. Eur J Gastroenterol Hepatol (2000) 0.81
Description and sources of contamination by Campylobacter spp. of river water destined for human consumption in Brittany, France. Pathol Biol (Paris) (2009) 0.81
Characterization of Micrococcaceae strains isolated from the human urogenital tract by the conventional scheme and a micromethod. J Clin Microbiol (1985) 0.81